High-yield, in vitro protein expression using a continuous-exchange, coupled transcription/ translation system. Export

@article{citeulike:2649758, abstract = {The Rapid Translation System (RTS 500) (Roche Molecular Biochemicals) is a high-yield protein expression system that utilizes an enhanced E. coli lysate for an in vitro transcription/translation reaction. In contrast to conventional transcription/translation, this system allows protein expression to continue for more than 24 h. We demonstrated the utility of the RTS 500 by expressing different soluble and active proteins that generally pose problems in cell-based expression systems. We first expressed GFP-lunasin, a fusion protein that, because of its toxicity, has been impossible to produce in whole cells. The second protein we expressed, human interleukin-2 (IL-2), is generally difficult to produce, either as the native molecule or as a GSTfusion protein, in a soluble form in bacteria. Finally, we demonstrated the capacity of the RTS 500 to co-express proteins, by the simultaneous production of GFP and CAT in a single reaction. This new technology appears to be particularly usefulfor the convenient production of preparative amounts (100-900 microg) of proteins that are toxic or insoluble in cell-based systems.}, address = {Roche Diagnostics, Berkeley, CA, USA. george.martin@roche.com}, author = {Martin, G. A. and Kawaguchi, R. and Lam, Y. and DeGiovanni, A. and Fukushima, M. and Mutter, W.}, citeulike-article-id = {2649758}, citeulike-linkout-0 = {http://view.ncbi.nlm.nih.gov/pubmed/11680726}, citeulike-linkout-1 = {http://www.hubmed.org/display.cgi?uids=11680726}, issn = {0736-6205}, journal = {BioTechniques}, keywords = {lunasin}, month = {October}, number = {4}, posted-at = {2008-04-10 16:29:45}, priority = {2}, title = {High-yield, in vitro protein expression using a continuous-exchange, coupled transcription/ translation system.}, url = {http://view.ncbi.nlm.nih.gov/pubmed/11680726}, volume = {31}, year = {2001} }

TY - JOUR ID - citeulike:2649758 L3 - citeulike-article-id:2649758 N2 - The Rapid Translation System (RTS 500) (Roche Molecular Biochemicals) is a high-yield protein expression system that utilizes an enhanced E. coli lysate for an in vitro transcription/translation reaction. In contrast to conventional transcription/translation, this system allows protein expression to continue for more than 24 h. We demonstrated the utility of the RTS 500 by expressing different soluble and active proteins that generally pose problems in cell-based expression systems. We first expressed GFP-lunasin, a fusion protein that, because of its toxicity, has been impossible to produce in whole cells. The second protein we expressed, human interleukin-2 (IL-2), is generally difficult to produce, either as the native molecule or as a GSTfusion protein, in a soluble form in bacteria. Finally, we demonstrated the capacity of the RTS 500 to co-express proteins, by the simultaneous production of GFP and CAT in a single reaction. This new technology appears to be particularly usefulfor the convenient production of preparative amounts (100-900 microg) of proteins that are toxic or insoluble in cell-based systems. IS - 4 JF - BioTechniques SN - 0736-6205 AD - Roche Diagnostics, Berkeley, CA, USA. george.martin@roche.com TI - High-yield, in vitro protein expression using a continuous-exchange, coupled transcription/ translation system. VL - 31 KW - lunasin AU - Martin, GA AU - Kawaguchi, R AU - Lam, Y AU - DeGiovanni, A AU - Fukushima, M AU - Mutter, W PY - 2001/10// UR - http://view.ncbi.nlm.nih.gov/pubmed/11680726 ER -